R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Cited by (1,000)

Items 301–400 of 1,000

1. Mechanism of N6-methyladenosine modification and its emerging role in cancer
   Sicong Zhang · 2018 · Pharmacology & Therapeutics
2. The dynamics of FTO binding and demethylation from the m6A motifs
   Yixing Li, Kejing Wu, Weili Quan, Lin Yu, Shuang Chen, Chao Cheng, Qijia Wu, Shuhong Zhao, Yi Zhang, Lei Zhou · 2019 · RNA Biology
3. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer
   Zhijun Zhou, Junxia Zhang, Chao Xu, Jingxuan Yang, Yuqing Zhang, Mingyang Liu, Xiuhui Shi, Xiaoping Li, Hanxiang Zhan, Wei Chen et al. · 2021 · EBioMedicine
4. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
   Zhixian Liang, Reilly L. Kidwell, Haijing Deng, Qi Xie · 2020 · Cancer Biology and Medicine
5. Novel Insights into Adipogenesis from the Perspective of Transcriptional and RNA N6‐Methyladenosine‐Mediated Post‐Transcriptional Regulation
   Tongxing Song, Yang Yang, Siwen Jiang, Jian Peng · 2020 · Advanced Science
6. Protective role of mRNA demethylase FTO on axon guidance molecules of nigro-striatal projection system in manganese-induced parkinsonism
   Zhipeng Qi, Shuang Wang, Jiashuo Li, Yi Wen, Rong Cui, Ke Zhang, Yanan Liu, Xinxin Yang, Lei Zhang, Bin Xu et al. · 2021 · Journal of Hazardous Materials
7. Advances in targeting RNA modifications for anticancer therapy
   Monica M. Pomaville, Chuan He · 2023 · Trends in cancer
8. Emerging Role and Mechanism of the FTO Gene in Cardiovascular Diseases
   Ziyang Xu, Xia Jing, Xing‐dong Xiong · 2023 · Biomolecules
9. N6-methyladenine modification in noncoding RNAs and its function in cancer
   Xinyu Yang, Xiang Hu, Jinting Liu, Ruiqing Wang, Chen Zhang, Fengjiao Han, Yuhong Chen, Daoxin Ma · 2020 · Biomarker Research
10. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology
    Xinyu Fang, Mengyang Li, Tao Yu, Gaoli Liu, Jianxun Wang · 2020 · Genes & Diseases
11. RNA modifications in hematopoietic malignancies: a new research frontier
    Ying Qing, Rui Jun Su, Jianjun Chen · 2021 · Blood
12. RNA m 6 A methylation in cancer
    Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, Lichen Ge, Jiexin Li, Hongsheng Wang · 2022 · Molecular Oncology
13. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties
    Pan Xiao, Zongliang Duan, Zeyu Liu, Liang Chen, Deyan Zhang, Lu Liu, Chen Zhou, Jianhua Gan, Ze Dong, Cai‐Guang Yang · 2023 · Journal of Medicinal Chemistry
14. Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
    Jing Chen, Kun Yu, Guansheng Zhong, Wei Shen · 2020 · Cancer Cell International
15. N 6 ‐methyladenosine (m 6 A) RNA modification in human cancer
    Fu‐Chun Huo, Zhi‐Man Zhu, Dong‐Sheng Pei · 2020 · Cell Proliferation
16. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer
    Qunying Wu, Xing Xie, Yiming Huang, Shanshan Meng, Youcheng Li, Hui-Feng Wang, Yanling Hu · 2020 · Journal of Cancer
17. FTO inhibits UPRmt-induced apoptosis by activating JAK2/STAT3 pathway and reducing m6A level in adipocytes
    Zhentong Shen, Ping Liu, Qian Sun, Yizhou Li, Rabin Acharya, Xinjian Li, Chao Sun · 2021 · APOPTOSIS
18. Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications
    Tian Jin Tang, Yingli Han, Yuran Wang, He Huang, Pengxu Qian · 2021 · Frontiers in Cell and Developmental Biology
19. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq
    Wei Li, Xiaoyu Li, Xunjie Ma, Wei Xiao, Jingjing Zhang · 2022 · BMC Genomics
20. m6A-express: uncovering complex and condition-specific m6A regulation of gene expression
    Teng Zhang, Shao‐Wu Zhang, Song-Yao Zhang, Shou‐Jiang Gao, Yidong Chen, Yufei Huang · 2021 · Nucleic Acids Research
21. Structure–Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors
    Zeyu Liu, Zongliang Duan, Deyan Zhang, Pan Xiao, Tao Zhang, Hongjiao Xu, Chuan-Hui Wang, Guo-Wu Rao, Jianhua Gan, Yue Huang et al. · 2022 · Journal of Medicinal Chemistry
22. Emerging roles of m6A RNA modification in cancer therapeutic resistance
    Weiwei Liu, Zhongyuan Zhang, Fei Wang, Hao Wang · 2023 · Experimental Hematology and Oncology
23. N6-methyladenosine(m6A) demethylase FTO regulates cellular apoptosis following cobalt-induced oxidative stress
    Jianping Tang, Qianqian Su, Zhenkun Guo, Jinfu Zhou, Fuli Zheng, Guangxia Yu, Wenya Shao, Hong Hu, Siying Wu, Huangyuan Li · 2021 · Environmental Pollution
24. A feedback loop engaging propionate catabolism intermediates controls mitochondrial morphology
    Junxiang Zhou, Mei Duan, Xin Wang, Fengxia Zhang, Hejiang Zhou, Tengfei Ma, Qiuyuan Yin, Jie Zhang, Fei Tian, Guodong Wang et al. · 2022 · Nature Cell Biology
25. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner
    Peizhang Li, Yuanping Shi, Dajun Gao, Huan Xu, Yun Zou, Zhong Wang, Wenzhi Li · 2022 · International Journal of Biological Sciences
26. Small molecule inhibitors targeting m6A regulators
    Guotai Feng, Yongya Wu, Yuan Hu, Shuai Wen, Xiao Jun Yang, Yong Li, Liang Ouyang, Guan Wang · 2024 · Journal of Hematology & Oncology
27. It's complicated… m6A-dependent regulation of gene expression in cancer
    Christina M. Fitzsimmons, Pedro J. Batista · 2018 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
28. Impacts of cannabinoid epigenetics on human development: reflections on Murphy et. al. ‘cannabinoid exposure and altered DNA methylation in rat and human sperm’ epigenetics 2018; 13: 1208-1221.
    Albert Stuart Reece, Gary Kenneth Hulse · 2019 · Epigenetics
29. Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation
    Shuitu Feng, Guoqin Qiu, Lihong Yang, Lihua Feng, Xin Fan, Fang Ren, Kaida Huang, Yide Chen · 2021 · Bioscience Reports
30. N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer
    Shenghua Dong, Yutong Wu, Yadi Liu, Hengyou Weng, Huilin Huang · 2021 · 癌症：英文版
31. Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer
    Shuoran Tian, Junzhong Lai, Tingting Yu, Qiumei Li, Qi Chen · 2021 · Frontiers in Oncology
32. Meclofenamic Acid Restores Gefinitib Sensitivity by Downregulating Breast Cancer Resistance Protein and Multidrug Resistance Protein 7 via FTO/m6A-Demethylation/c-Myc in Non-Small Cell Lung Cancer
    Hui Chen, Bin Jia, Qiang Zhang, Yu Zhang · 2022 · Frontiers in Oncology
33. METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression
    Zihao Dai, Wanjie Zhu, Yingdong Hou, Xinyue Zhang, Xuxin Ren, Kai Lei, Junbin Liao, Hai‐Ning Liu, Zhihang Chen, Sui Peng et al. · 2023 · Molecular Therapy
34. Small changes, big implications: The impact of m6A RNA methylation on gene expression in pluripotency and development
    Adam M. Heck, Carol J. Wilusz · 2019 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
35. N6-Methyladenosine: A Potential Breakthrough for Human Cancer
    Lina Liu, Yuwei Wang, Jie Wu, Jingwen Liu, Zongchang Qin, Hong Bo Fan · 2019 · Molecular Therapy — Nucleic Acids
36. N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.
    Song Xiang, Xiaolong Liang, Shuo Yin, Jian Liu, Zheng Xiang · 2020 · PubMed Central
37. The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers
    Jinyan Wang, Lijuan Chen, Ping Qiang · 2020 · OncoTargets and Therapy
38. Recent developments of small molecules targeting RNA m6A modulators
    Jing Gu, Jun Qiang Xu, Qidong You, Xiaoke Guo · 2020 · European Journal of Medicinal Chemistry
39. Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach
    Muthuraj Prakash, Yukihiro Itoh, Yoshie Fujiwara, Yukari Takahashi, Yuri Takada, Paolo Mellini, Elghareeb E. Elboray, Mitsuhiro Terao, Yasunobu Yamashita, Chika Yamamoto et al. · 2021 · Journal of Medicinal Chemistry
40. RNA m6A methylation regulators in ovarian cancer
    Jialu Guo, Jianfeng Zheng, Huizhi Zhang, Jinyi Tong · 2021 · Cancer Cell International
41. m6A: An Emerging Role in Programmed Cell Death
    Fajuan Tang, Lin Chen, Hu Gao, Dongqiong Xiao, Xihong Li · 2022 · Frontiers in Cell and Developmental Biology
42. The FTO m6A demethylase inhibits the invasion and migration of prostate cancer cells by regulating total m6A levels
    Kai Zhu, Ying Li, Yikai Xu · 2021 · Life Sciences
43. YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation
    Amalie Grenov, Hadas Hezroni, Lior Lasman, Jacob H. Hanna, Ziv Shulman · 2022 · Cell Reports
44. SFPQ Is an FTO-Binding Protein that Facilitates the Demethylation Substrate Preference
    Haiping Song, Ye Wang, Ruixiang Wang, Xiao Zhang, Yaping Liu, Guifang Jia, Peng R. Chen · 2020 · Cell chemical biology
45. N 6 -methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction
    Jinming Li, Lei Liang, Yongzhi Peter Yang, Xinxiang Li, Yanlei Ma · 2021 · Theranostics
46. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin
    Yan Wang, Zhiqiang Cheng, Jing Xu, Meina Lai, Liming Liu, Min Zuo, Lin Dang · 2021 · Bioengineered
47. Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape
    Wei Li, Yi Hao, Xingda Zhang, Shouping Xu, Da Pang · 2022 · Molecular Cancer
48. The biological function of m6A methyltransferase KIAA1429 and its role in human disease
    Xiaoyu Zhang, Meng jiao Li, Lei Xia, Hairong Zhang · 2022 · PeerJ
49. N6-Methyladenosine Role in Acute Myeloid Leukaemia
    Zaira Ianniello, Alessandro Fatica · 2018 · International Journal of Molecular Sciences
50. RNA N 6-Methyladenosine Modification in Normal and Malignant Hematopoiesis
    Hengyou Weng, Huilin Huang, Jianjun Chen · 2019 · Advances in experimental medicine and biology
51. N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability
    Libin Zou, Wenbin Chen, Xumin Zhou, Taowei Yang, Junqi Luo, Zining Long, Jun Wu, Daojun Lv, Xiangming Mao, Shengren Cen · 2022 · Cell Death Discovery
52. Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
    Peng Xu, Kang Hu, Ping Zhang, Zhigang Sun, Nan Zhang · 2022 · Cancer Cell International
53. Cyclodextrin-Functionalized Gold Nanorods Loaded with Meclofenamic Acid for Improving N6-Methyladenosine-Mediated Second Near-Infrared Photothermal Immunotherapy
    Jianhua Liu, Yue Song, Yiqiao Wang, Mingda Han, Chunxi Wang, Fei Yan · 2022 · ACS Applied Materials & Interfaces
54. RNA-binding proteins in cancer drug discovery
    Jean Borges Bertoldo, Simon Müller, Stefan Hüttelmaier · 2023 · Drug Discovery Today
55. The Role of Dynamic m6A RNA Methylation in Photobiology
    Myles Robinson, Palak Shah, Yan‐Hong Cui, Yu‐Ying He · 2018 · Photochemistry and Photobiology
56. Identification of nafamostat mesilate as an inhibitor of the fat mass and obesity-associated protein (FTO) demethylase activity
    Xinxin Han, Ning Wang, Junya Li, Ying Wang, Ruiyong Wang, Junbiao Chang · 2018 · Chemico-Biological Interactions
57. MYC promotes cancer progression by modulating m6A modifications to suppress target gene translation
    Gongwei Wu, Caixia Suo, Ying Yang, Shengqi Shen, Linchong Sun, Shiting Li, Yingli Zhou, Dongdong Yang, Yan Wang, Yongping Cai et al. · 2021 · EMBO Reports
58. The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
    Yue Xi Shi, Yanliang Dou, Jianye Zhang, Jie Qi, Zijuan Xin, Mingxin Zhang, Yu Pei Xiao, Weimin Ci · 2021 · Frontiers in Cell and Developmental Biology
59. PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1
    Rawat, Vipin, Malvi, Parmanand, Della Manna, Deborah, Yang, Eddy S., Bugide, Suresh, Zhang, Xuchen, Gupta, Romi, Wajapeyee, Narendra · 2021 · Oncogene
60. Macrophages activated by hepatitis B virus have distinct metabolic profiles and suppress the virus via IL-1β to downregulate PPARα and FOXO3
    Yumei Li, Yanwen Zhu, Shu Ying Feng, Yuji Ishida, Tsu-Pei Chiu, Takeshi Saito, Sean Wang, David Kong Ann, Jing‐hsiung James Ou · 2022 · Cell Reports
61. The potential role of m6A modifications on immune cells and immunotherapy
    Linchuan Gan, Yuxiang Zhao, Yajuan Fu, Qi Chen · 2023 · Biomedicine & Pharmacotherapy
62. Towards a druggable epitranscriptome: Compounds that target RNA modifications in cancer
    María Berdasco, Manel Esteller · 2021 · British Journal of Pharmacology
63. UiO-66 MOFs-Based “Epi-Nano-Sonosensitizer” for Ultrasound-Driven Cascade Immunotherapy against B-Cell Lymphoma
    Zhihua Wang, Mingda Han, Yiqiao Wang, Ning Wang, Yilin Yang, Bingru Shao, Qiannan Miao, Zhan Shi, Fei Yan, Shouhua Feng · 2025 · ACS Nano
64. Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system
    Hiroaki Takei, Jun Shinoda, Soko Ikuta, Takashi Maruyama, Yoshihiro Muragaki, Tomohiro Kawasaki, Yuka Ikegame, Makoto Okada, Takeshi Ito, Yoshitaka Asano et al. · 2019 · Journal of neurosurgery
65. IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma
    Sha Song, Fan Gao, Qi Li, Qi Su, Xinyun Zhang, Xiaofeng Xue, Zhiming Wang, Chenao Qian, Zhou Jin, Bing-Zong Li et al. · 2021 · Oncogene
66. Prognostic Impact of IGF2BP3 Expression in Patients with Surgically Resected Lung Adenocarcinoma
    Wei Guo, Qilin Huai, Huan Ying Wan, Lei Guo, Peng Song, Shugeng Gao, Jie He · 2021 · DNA and Cell Biology
67. FTO: a critical role in obesity and obesity-related diseases
    Dan Yin, Yiyang Li, Xingyue Liao, Dewei Tian, Yunsi Xu, Cuilan Zhou, Jun Liu, Suyun Li, Jing Zhou, Yulin Nie et al. · 2023 · British Journal Of Nutrition
68. METTL3-mediated m6A RNA methylation induces the differentiation of lung resident mesenchymal stem cells into myofibroblasts via the miR-21/PTEN pathway
    Yi Chao Lu, Zeyu Liu, Yunjiao Zhang, Xiuhua Wu, Wei Bian, Shan Shan, Danrong Yang, Tao Ren · 2023 · Respiratory Research
69. IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
    Kristian A. Choate, Evan P.S. Pratt, Matthew James Jennings, Robert J. Winn, Paul B. Mann · 2024 · Biology
70. N6‑methyladenine RNA modification and cancer (Review)
    Yang Jun, Junwen Chen, Xiang Fei, Xia Wang, Kefeng Wang · 2020 · Oncology Letters
71. The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors
    Yiyang Zheng, Yanyan Luo, Xixi Chen, Huiting Li, Baojun Huang, Baofeng Zhou, Liqing Zhu, Xianhui Kang, Wujun Geng · 2021 · Molecular Cancer
72. The rs1421085 variant within FTO promotes brown fat thermogenesis
    Zhiyin Zhang, Na Chen, Nan Yin, Ruixin Liu, Yang He, Danjie Li, Muye Tong, Aibo Gao, Peng Lu, Yuxiao Zhao et al. · 2023 · Nature Metabolism
73. Identification of Clausine E as an inhibitor of fat mass and obesity‐associated protein (FTO) demethylase activity
    Ying Wang, Junya Li, Xinxin Han, Ning Wang, Chuanjun Song, Ruiyong Wang, Junbiao Chang · 2019 · Journal of Molecular Recognition
74. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases
    P. K. Annapoorna, Harish Iyer, Tanvi Parnaik, Harish Narasimhan, Arnav Bhattacharya, Arvind Kumar · 2019 · Neuroscience
75. Malic enzyme 2 maintains protein stability of mutant p53 through 2-hydroxyglutarate
    Mengjia Zhao, Pengbo Yao, Youxiang Mao, Jinjun Wu, Weihua Wang, Chenhui Geng, Jie Cheng, Wenjing Du, Peng Jiang · 2022 · Nature Metabolism
76. Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents
    Junya Lv, Lijuan Xing, Xin Zhong, Kai Li, Mingyan Liu, Ke Du · 2023 · Biomedicine & Pharmacotherapy
77. RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression
    Zhenglai Zhang, Keren Zhou, Li Han, Andrew Small, Jingling Xue, Huilin Huang, Hengyou Weng, R. Su, Brandon Tan, Chao Shen et al. · 2023 · Genes and Diseases
78. The Fat Mass‐ and Obesity‐Associated (FTO) Gene to Obesity: Lessons from Mouse Models
    Jeong Yoon Chang, Joo Hyun Park, Sung Eun Park, Jinyoung Shon, Yoon Jung Park · 2018 · Obesity
79. Epitranscriptomic m6A modification in the stem cell field and its effects on cell death and survival.
    Jiaxin Chen, Chan Wang, Weiqiang Fei, Xiao Fang, Xiaotong Hu · 2019 · PubMed Central
80. Insights into the Regulatory Role of m6A Epitranscriptome in Glioblastoma
    Silvia Galardi, Alessandro Michienzi, Silvia Anna Ciafrè · 2020 · International Journal of Molecular Sciences
81. The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance
    Shaun Wood, Amber R. Willbanks, Jason Xiaojun Cheng · 2021 · Current Cancer Drug Targets
82. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
    Xianyong Zhou, Chen Li, Tong Chen, Wenhao Li, Xiaolong Wang, Qifeng Yang · 2023 · Molecular Cancer
83. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
    Dan Wang, Yingying Han, Lushan Peng, Tao Huang, Xiaoyun He, Junpu Wang, Chunlin Ou · 2023 · International Journal of Biological Sciences
84. m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation
    Yujiao Liu, Jia Li, Jie Xu, Yingfei Long, Yuan Wang, Xiaoyi Liu, Junchi Hu, Qinglv Wei, Qingya Luo, Fatao Luo et al. · 2024 · Oncogene
85. Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis
    Derek Dang, Akash Deogharkar, John McKolay, Kyle S. Smith, Pooja Panwalkar, SIMON S. HOFFMAN, Wentao Tian, Sunjong Ji, Ana Paula Azambujá, Siva Kumar Natarajan et al. · 2025 · Cancer Cell
86. Expression Profiles and Prognostic Roles of m6A Writers, Erasers and Readers in Gastric Cancer
    Jingjing Jing, Xu Zhao, Hao Ran Li, Liping Laura Sun, Yuan Yuan · 2021 · Future Oncology
87. Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
    Xuan Han, Yu Zhu, Juan Ke, Yufeng Zhai, Min Huang, Xin Zhang, Hongjie He, Xiao‐Jing Zhang, Xuehong Zhao, Kaikai Guo et al. · 2024 · Cell Death Discovery
88. Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2
    Deguan Lv, Deobrat Dixit, Andrea F. Cruz, Leo J.Y. Kim, Likun Duan, Xin Yun Xu, Qiulian Wu, Cuiqing Zhong, Chenfei Lu, Zachary Charles Gersey et al. · 2024 · Cell Metabolism
89. The role of m6A modification in pediatric cancer
    Yongping Chen, Lei Miao, Huiran Lin, Zhenjian Zhuo, Jing He · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
90. Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis
    Yue Gao, Siyu Zhang, Xianhong Zhang, Yitian Du, Ting Ni, Shuailin Hao · 2024 · iScience
91. RNA modifications in gene regulation: Functions and pathways
    Jiangbo Wei, Chuan He · 2026 · Cell
92. Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer
    Jie Hou, Zhan Wang, Hong Li, Hongzhi Zhang, Lan Luo · 2020 · Frontiers in Genetics
93. Detection methods of epitranscriptomic mark N6-methyladenosine
    Ye Wang, Guifang Jia · 2020 · Essays in Biochemistry
94. N 6 -methyladenosine (m 6 A) in pancreatic cancer: Regulatory mechanisms and future direction
    Jian Li, Fangjuan Wang, Yongkang Liu, Huaizhi Wang, Bing Ni · 2021 · International Journal of Biological Sciences
95. The role of RNA modification in hepatocellular carcinoma
    Qiang Feng, Dongxu Wang, Tianyi Xue, Chao Lin, Yongjian Gao, Liqun Sun, Ye Jin, Dianfeng Liu · 2022 · Frontiers in Pharmacology
96. YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity
    Haiyan Zhang, Xiao-Jing Luo, Wei Yang, Zhiying Wu, Zhicong Zhao, Xin Pei, Xue Zhang, Chonghao Chen, Josh Haipeng Lei, Qingxia Shi et al. · 2024 · Nature Communications
97. TCA cycle-derived oncometabolites in cancer and the immune microenvironment
    Shukla Sarkar, Chien-I Chang, Jussekia Jean, Meng‐Ju Wu · 2025 · Journal of Biomedical Science
98. Dual effects of N6-methyladenosine on cancer progression and immunotherapy
    Hui Li, Hao Wu, Qin Wang, Shipeng Ning, Shouping Xu, Da Pang · 2021 · Molecular Therapy — Nucleic Acids
99. Regulation of m6A Methylation as a New Therapeutic Option against COVID-19
    Carla Zannella, Luca Rinaldi, Giovanni Boccia, Annalisa Chianese, Ferdinando Carlo Sasso, Francesco De Caro, Gianluigi Franci, Massimiliano Galdiero · 2021 · Pharmaceuticals
100. The Role of m6A on Female Reproduction and Fertility: From Gonad Development to Ovarian Aging
     Xiaoyan Sun, Jiafeng Lu, Hong Li, Boxian Huang · 2022 · Frontiers in Cell and Developmental Biology